1. Home
  2. EYE vs CNTA Comparison

EYE vs CNTA Comparison

Compare EYE & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$28.69

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$26.51

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYE
CNTA
Founded
1990
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
EYE
CNTA
Price
$28.69
$26.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
11
Target Price
$27.11
$37.70
AVG Volume (30 Days)
1.6M
1.8M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,921,355,000.00
$15,000,000.00
Revenue This Year
$9.80
N/A
Revenue Next Year
$4.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.33
118.88
52 Week Low
$9.93
$9.60
52 Week High
$29.87
$30.58

Technical Indicators

Market Signals
Indicator
EYE
CNTA
Relative Strength Index (RSI) 57.73 45.51
Support Level $27.63 $28.43
Resistance Level $29.87 $30.02
Average True Range (ATR) 1.21 1.34
MACD 0.11 -0.40
Stochastic Oscillator 66.62 18.64

Price Performance

Historical Comparison
EYE
CNTA

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: